Miriplatin
Miriplatin is a drug used to treat hepatocellular carcinoma. It is a lipophilic platinum complex that is used in transcatheter arterial chemoembolization. Miriplatin was approved by Japan's Pharmaceuticals and Medical Devices Agency in 2009.